0001062993-19-002408.txt : 20190524
0001062993-19-002408.hdr.sgml : 20190524
20190524192305
ACCESSION NUMBER: 0001062993-19-002408
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190522
FILED AS OF DATE: 20190524
DATE AS OF CHANGE: 20190524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mattila Jyrki
CENTRAL INDEX KEY: 0001297318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19855704
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 40 VALLEY STREAM PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-05-22
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001297318
Mattila Jyrki
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2019-05-22
4
M
0
15000
37.64
A
15376
D
Common Stock, $0.001 par value
2019-05-22
4
M
0
3750
41.82
A
19126
D
Common Stock, $0.001 par value
2019-05-22
4
S
0
18750
62.06
D
376
D
Stock Option (right to buy)
37.64
2019-05-22
4
M
0
15000
0
D
2025-04-22
Common Stock
15000
0
D
Stock Option (right to buy)
41.82
2019-05-22
4
M
0
3750
0
D
2028-03-15
Common Stock
3750
11250
D
The options were granted on April 22, 2015 and vested in four equal annual installments beginning on the first anniversary of the grant date.
The options were granted on March 15, 2018, and vest in four equal annual installments beginning on the first anniversary of the grant date.
/s/Jyrki Mattila, by Carl A. Valenstein, attorney-in-fact
2019-05-24